ReviewCardiovascular drugs and therapy2021

A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs.

Wen-Liang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.